Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eliot Mostow MD, MPH
Eliot N. Mostow MD, MPH Associate Editor
Jane Grant-Kels MD, FAAD
Jane M. Grant-Kels MD, FAAD Advisory Board
Ashish Bhatia MD, FAAD
Ashish C. Bhatia MD, FAAD Associate Editor
See All Experts
Published in Dermatology

News · March 19, 2024

AAD 2024: Upadacitinib Improves Skin Repigmentation for Adults With Nonsegmental Vitiligo

Doses of 11 mg and 22 mg achieved clinically meaningful outcomes on the Facial Vitiligo Area Scoring Index and Total Vitiligo Area Scoring Index

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated